Ratio of interventricular septal thickness to global longitudinal strain accurately identifies cardiac amyloidosis
If validated in prospective multi-centre studies, the routine measurement of IVSd/GLS can assist with earlier diagnosis of CA, resulting in earlier initiation of treatment in this underserved population.
Authors
- Piero Ricchiuto (ORCID: https://orcid.org/0000-0002-8525-6624)
- Gloria J. Hong (ORCID: https://orcid.org/0000-0003-1572-2359)
- Michael Abiragi (ORCID: https://orcid.org/0000-0003-2824-9206)
- Louie Cao (ORCID: https://orcid.org/0000-0002-9680-5801)
- Jonathan Le
- Phillip Ryan Tacon
- L. Stern (ORCID: https://orcid.org/0000-0003-3024-9563)
- Chathuri Daluwatte
- David Ouyang (ORCID: https://orcid.org/0000-0002-3813-7518)
- J. Patel (ORCID: https://orcid.org/0000-0003-0618-6750)
- I-Min Chiu (ORCID: https://orcid.org/0000-0001-6876-8217)
Institutions
- Cedars-Sinai Medical Center (US)
- Alexion Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Open Heart
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/openhrt-2024-003120
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alexion Pharmaceuticals